Redeye: Proact - Third Consecutive Solid Quarter
Redeye retains its positive view of Proact following a strong Q4 report fueled by System sales. However, the organic growth in recurring revenue accelerated as well. We raise our forecasts and Base Case slightly.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/